Tuesday, February 5, 2013

• NPS Pharmaceuticals to Present at Upcoming ConferencesBusiness Wire (Tue, Feb 5)
• Are Drugs for Ultra-Rare Diseases the Future of Biotech? Francois Nader of NPS Weighs Inat Forbes (Tue, Feb 5)

Wednesday, January 30, 2013

• New Peer-reviewed Publication Offers Guidance for Integrating Gattex® (Teduglutide [rDNA origin]) for Injection into Management of Short Bowel SyndromeBusiness Wire (Wed, Jan 30)

Friday, January 25, 2013

• 3 Reasons to Buy NPS Pharmaceuticalsat Motley Fool (Fri, Jan 25)

Friday, January 18, 2013

• Big Pharma's Special Sauceat Motley Fool (Fri, Jan 18)
• Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013Marketwired (Fri, Jan 18)
• Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharmaat TheStreet (Fri, Jan 18)

Thursday, January 17, 2013

• Do Orphan Drug Developers Belong in Your Portfolio?at Motley Fool (Thu, Jan 17)

Wednesday, January 16, 2013

• 3 High-Growth Healthcare Stocks With Bearish Short Trendsat Seeking Alpha (Wed, Jan 16)

Tuesday, January 15, 2013

• 3 Drug Launches You Need to Know in 2013at Motley Fool (Tue, Jan 15)

Wednesday, January 9, 2013

• NPS Pharmaceuticals' CEO Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript)at Seeking Alpha (Wed, Jan 9)

Tuesday, January 8, 2013

• Cramer: Sell Hudson City, iShares Silver Trust and Buy KeyCorp and These 2 Performersat Wall St. Cheat Sheet (Tue, Jan 8)
• Cramer's Top Stock Picks: NPSP BAC EXASat TheStreet (Tue, Jan 8)

Monday, January 7, 2013

• Cramer's 'Mad Money' Recap: Safe Harbors for Investmentat TheStreet (Mon, Jan 7)
• Cramer: Real Opportunity in This Drug Makerat CNBC (Mon, Jan 7)
• [video] NPS Pharmaceuticals CEO on Gattex's FDA Approvalat CNBC (Mon, Jan 7)
• [video] Mad Money, January 7, 2013at CNBC (Mon, Jan 7)
• BioMarin Goes Shoppingat Motley Fool (Mon, Jan 7)

Thursday, January 3, 2013

• NPS Pharma: Controversy Over Super-Expensive Orphan Drug Pricesat TheStreet (Thu, Jan 3)
• Inside The Pricing Of A $300,000-A-Year Drugat Forbes (Thu, Jan 3)
• NPS Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceBusiness Wire (Thu, Jan 3)

Wednesday, January 2, 2013

• NPS Pharmaceuticals' CEO Discusses FDA Approval and Commercial launch of Gattex (Transcript)at Seeking Alpha (Wed, Jan 2)
• NPS Pharmaceuticals to Host Conference Call to Discuss FDA Approval of Gattex® (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel SyndromeBusiness Wire (Wed, Jan 2)

Thursday, December 27, 2012

• NPS Pharmaceuticals forms distribution, clinical service network for Gattextheflyonthewall.com (Thu, Dec 27)
• NPS Pharmaceuticals Signs Agreements with Leading Specialty Home Infusion Providers to Support Distribution and Home-based Clinical Care Services for Gattex®Business Wire (Thu, Dec 27)

Add NPSP News to My Yahoo!